Mice Model Market: Applications in Oncology Research and Cancer Treatment

1. Mice Model Market: Overcoming the High Costs and Skilled Personnel Shortages in Research

2. Global XXX Market – 2023-2030 The mice model market is set for significant growth, with various segments showing strong demand across different applications, technologies, and services. Here's a closer look at how the market is expected to unfold in 2023. Request pdf @ https://www.meticulousresearch.com/download-sample- report/cp_id=4151 1. Services: Breeding Segment Leading the Market In 2023, the breeding services segment is expected to hold the largest share of the mice model market. This dominance is primarily driven by the growing demand for customized mice models used in research applications, particularly in fields such as oncology and cardiovascular disease studies. Customized breeding services allow researchers to create mice with specific genetic traits, making them essential for studying complex diseases and testing new treatments. 2. Technology: CRISPR/CAS9 Takes Center Stage When it comes to technology, the CRISPR/CAS9 segment is anticipated to account for the largest share of the market in 2023. This cutting-edge gene-editing technology is preferred due to its high precision, cost-effectiveness, and speed in creating genetically modified mice. CRISPR/CAS9's ability to accurately alter specific genes makes it invaluable for advancing research in genetics, disease modeling, and therapeutic development. 3. Application: Oncology Studies Dominate The application of mice models in oncology research is expected to dominate the market in 2023. This large market share is attributed to the increasing need for targeted cancer therapies, the rising prevalence of cancer globally, and substantial research funding dedicated to cancer studies. Mice models play a crucial role in understanding tumor biology, testing new cancer drugs, and developing personalized cancer treatment strategies. 4. End Users: Pharmaceutical & Biotechnology Companies Lead Pharmaceutical and biotechnology companies are expected to be the primary end users of mice models in 2023. This segment's large market share is due to substantial investments in drug development, high research and development (R&D) expenditure, and the growing demand for the rapid creation of new and effective drugs. Mice models are indispensable tools for these companies, enabling them to conduct preclinical trials and evaluate the safety and efficacy of potential treatments. Geographic Overview: North America at the Forefront The mice model market is analyzed across key regions, including North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa. In 2023, North America is projected to hold the largest share of the market, followed by Europe and Asia-Pacific. The leading position of North America is largely due to its advanced research and development infrastructure, the presence of major pharmaceutical and biotechnology companies, and substantial R&D funding from both government and private sectors. This well-established ecosystem supports the continuous advancement and adoption of mice models for various scientific and medical research applications. Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. Global XXX Market – 2023-2030 As the mice model market continues to expand, these key segments and regional dynamics highlight the critical areas of growth and investment. With ongoing advancements in gene-editing technologies and the increasing demand for personalized medicine, the mice model market is poised for significant innovation and development in the coming years. Key Players in the Mice Model Market The mice model market is highly competitive, with key players including: •Charles River Laboratories International, Inc. (U.S.) •The Jackson Laboratory (U.S.) •Laboratory Corporation of America Holdings (U.S.) •Horizon Discovery Group plc (U.K.) •Trans Genic Inc. (Japan) •GenOway S.A. (France) •Taconic Biosciences, Inc. (U.S.) •Envigo Ltd (U.S.) •Janvier Labs (France) •Ingenious Targeting Laboratory (U.S.) •Harbour Antibodies B.V. (China) (a subsidiary of HBM Holdings) •Crescendo Biologics Ltd. (U.K.) •Deltagen Inc. (U.S.) •ImmunoGenes Kft. (Hungary) These companies play a pivotal role in the market, focusing on innovative technologies and expanding their product offerings to cater to the growing demand. Future Outlook for the Mice Model Market The mice model market is segmented by various factors, including mice type, services, technology, application, end user, and geography. This segmentation helps to understand the market dynamics and identify growth opportunities in different areas. Mice Type Segment: Inbred Mice Leading the Way In 2023, the inbred mice segment is expected to dominate the market, holding the largest share. This is primarily due to the high demand for inbred mice, which are known for their unique genetic makeup and ability to produce consistent and reliable results in experimental studies. Inbred mice are widely used in research because they provide a controlled environment to study genetic variations and disease mechanisms, making them invaluable in scientific research. As the mice model market continues to grow, advancements in technology and increased focus on personalized medicine are likely to drive further developments, making this a dynamic and evolving sector. Contact Meticulous Email- sales@meticulousresearch.com Us: Research® Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. Global XXX Market – 2023-2030 Contact Connect research Connect with us on Twitter- https://twitter.com/MeticulousR123 Sales- +1-646-781-8004s LinkedIn- https://www.linkedin.com/company/meticulous- with us on Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com